Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Net Cash Flow (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Net Cash Flow for 15 consecutive years, with -$11.5 million as the latest value for Q1 2026.

  • For Q1 2026, Net Cash Flow rose 69.98% year-over-year to -$11.5 million; the TTM value through Mar 2026 reached $18.1 million, up 130.17%, while the annual FY2025 figure was -$8.6 million, 12.46% down from the prior year.
  • Net Cash Flow hit -$11.5 million in Q1 2026 for Corcept Therapeutics, down from -$4.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $233.6 million in Q1 2023 and bottomed at -$127.6 million in Q2 2023.
  • Average Net Cash Flow over 5 years is $1.8 million, with a median of -$4.6 million recorded in 2025.
  • Year-over-year, Net Cash Flow surged 2107.68% in 2022 and then plummeted 506.64% in 2023.
  • Corcept Therapeutics' Net Cash Flow stood at $16.1 million in 2022, then surged by 45.42% to $23.4 million in 2023, then plummeted by 137.9% to -$8.9 million in 2024, then surged by 47.99% to -$4.6 million in 2025, then plummeted by 148.75% to -$11.5 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$11.5 million, -$4.6 million, and $22.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.